Investing Profile

Liam Ratcliffe

InvestorVCAngel
Head of Biotechnology at Access Biotechnology
accessbio-tech.comNew York, New York
Photo of Liam Ratcliffe, Investor at Access Biotechnology
Your Intro Paths to Liam Ratcliffe

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Liam Ratcliffe on

cb
Current Investing Position
Access Biotechnology Investor
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
20

Liam Ratcliffe is on these Sector & Stage Rankings

Liam Ratcliffe's Investments On Record (12)

CompanyStageDateRound SizeTotal Raised
Eliem Therapeutics
Series BMay 2021$60M
Series AMar 2021$80M
$140M
Co-investors: Andrew Levin (RA Capital)
Shoopy
SeedFeb 2021$250K
$250K
Passage Bio
Series BSep 2019$110M
Series AFeb 2019$120M
$230M
Co-investors: Carl Gordon (OrbiMed), Patrick Heron (Frazier Healthcare Partners)
CuraSen Therapeutics
Series AOct 2018$55M
$55M
Arvinas
Series CApr 2018$55M
Series BOct 2015$42M
$110M
Co-investors: Colleen Cuffaro (Canaan Partners), Kush Parmar (5am Ventures), Stephen Squinto (OrbiMed), Tim Shannon (Canaan Partners), Andrew Levin (RA Capital), Daniel Wagner (Connecticut Innovations), Jakob Loven (Nextech Invest)
Aptinyx
Series BDec 2017$70M
Series AMay 2016$65M
$140M
Co-investors: Adam Koppel (Bain Capital Life Sciences)
Neuronetics
Series GJun 2017$15M
Series FApr 2015$34M
Series EMay 2011$30M
Series DOct 2009$30M
$170M
Co-investors: Bruce Cleveland (Wildcat Ventures), Leslie Bottorff (GE Ventures), Gil Kliman (InterWest), Kevin Bitterman (Atlas Venture)
Deciphera Pharmaceuticals
Series BSep 2015$75M
$75M